Eisai Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Eisai key operating metrics including Products in Pipeline (Neurology), environmental, and social and governance score (ESG).

Products in Pipeline (Neurology)

30.8%

Jul, 2020

Filed Trials Products (Gastrointestinal)

Jul, 2018

Trials Products Approved (Gastrointestinal)

66.7%

Jul, 2019

Operating Metrics

Metrics	Jul, 2018	Jul, 2019	Jul, 2020
Products in Pipeline (Neurology)	15	13	9
Filed Trials Products (Gastrointestinal)	1
Trials Products Approved (Gastrointestinal)	3	1
Phase II Trials Products (Gastrointestinal)	1	2
Phase III Trials Products (Gastrointestinal)	2	3
Products in Pipeline (Gastrointestinal)	7	4
Products in Pipeline (Oncology)	26	37	34
Filed Trials Products	6	9
Trials Products Approved	9	8
Phase I Trials Products	15	14
Phase II Trials Products	13	15
Phase I/II Trials Products	6	6
Phase III Trials Products	11	14
Phase II/III Trials Products	1	1
Phase I Trials Products (Oncology)	10	11
Phase II Trials Products (Oncology)	8	9
Phase I/II Trials Products (Oncology)	5	6
Phase III Trials Products (Oncology)	3	10
Filed Trials Products (Oncology)	2
Trials Products Approved (Oncology)	4	5
Phase I Trials Products (Neurology)	3	1
Phase II Trials Products (Neurology)	2	3
Phase III Trials Products (Neurology)	6	3
Phase II/III Trials Products (Neurology)	1	1
Filed Trials Products (Neurology)	3	9
Trials Products Approved (Neurology)	2	1
Phase I Trials Products (Gastrointestinal)		1

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub